blogs  
 
yournews
   
 
Video Photos Finance Travel Weather Discussion TV Shows
| |
 
  Home ›
 
World News

 

US, Europe offer H1N1 flu vaccine to nations in need
Posted: 18 September 2009 0425 hrs

 
 
Photos  of

   
 


WASHINGTON: The United States, France and Britain are among nine countries that pledged on Thursday to make 10 percent of their H1N1 flu vaccine supply available to other nations that may need it.

In recognition of the global nature of the pandemic, the United States is taking this action along with Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland, and Britain, the White House said in a statement.

The vaccine will be made available through the World Health Organisation (WHO), said White House Press Secretary Robert Gibbs.

In Paris, President Nicolas Sarkozy's office said that France will donate nine million H1N1 flu vaccine doses - 10 percent of its entire stock of 94 million doses of vaccines - to the WHO.

British International Development Secretary Douglas Alexander announced a similar donation.

The move is made "in recognition that diseases know no borders and that the health of the American people is inseparable from the health of people around the world," read the White House statement.

Swine flu cases are expected to increase as the northern hemisphere enters the fall season.

"We remain confident that the United States will have sufficient doses of the vaccine to ensure that every American who wants a vaccine is able to receive one," the White House said.

In Paris, the Elysee palace said that international solidarity "will be a determining factor in reducing the health, economic and social impact of the pandemic."

Britain "recognises that H1N1 is a global pandemic which requires a global response," Alexander said in London.

"Solidarity with other nations is vital, particularly the poorest who may be most vulnerable and have least capacity to respond," he added.

His comments came as official figures showed a steep rise in new H1N1 flu cases in England.

An estimated 5,000 new cases were reported last week, spurring the first uptick in cases since July.

Scotland also reported a "marked increase" in the number of people going to see their doctors with suspected H1N1 flu.

In Canada, a medical journal reported the first pandemic H1N1 flu outbreak of Canada's autumn flu season among remote aboriginal communities on Vancouver Island in the country's west.

Worldwide, at least 3,205 people have died of the virus since it was uncovered in Mexico in April, according to the WHO.

US drug regulators approved a single-dose H1N1 flu vaccine on Tuesday, which will be produced by four US manufacturers.

The US government has purchased 195 million doses of H1N1 flu vaccine and will make shots against the virus available free of charge starting next month, Health Secretary Kathleen Sebelius said, though providers might charge a fee to administer them.

Vaccination in the United States will be on a voluntary basis, with priority given to groups deemed to be especially at risk from the H1N1 flu virus.

High risk groups include pregnant women, people in contact with infants, medical personnel, people aged six months to 24 years, and adults under the age of 65 with underlying medical conditions. - AFP/de

 


Other world News
Blasts rock Syria's Aleppo, tanks enter Homs
Europe's Danube freezes over, cold snap toll at 460
Obama hails Italian PM in talks on euro crisis
Argentina to lodge Falklands protest at UN Friday
Palestinian leadership backs Fatah-Hamas Doha deal
British Islamists jailed for plotting terror attacks
Britain to defend Falklands right to self-determination: PM
US approves first nuclear plant in decades
US says it has not seen Egypt charges against NGO staff
Algeria's president sets May parliament polls
Steve Jobs' unflattering FBI files released
Cautious welcome for UN-Arab League mission in Syria
Obama to meet Italian PM on euro crisis
Syria unrest death toll rises
Syria's Homs under new deadly blitz

 

 
Affiliate Sites:
 
About Us  |  Contact Us  |  Advertise with Us  |  Terms & Conditions